The 'flare' phenomenon: should we be concerned?
- 1 July 2005
- journal article
- Published by Wiley in BJU International
- Vol. 96 (1) , 4-6
- https://doi.org/10.1111/j.1464-410x.2005.05556.x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Hormone Therapy in Prostate Cancer: LHRH Antagonists versus LHRH AnaloguesEuropean Urology, 2004
- Metastatic Prostate Cancer Treated by Flutamide versus Cyproterone Acetate: Final Analysis of the “European Organization for Research and Treatment of Cancer” (EORTC) Protocol 30892European Urology, 2004
- Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and GoserelinNew England Journal of Medicine, 1997
- Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trialBritish Journal of Urology, 1997
- Leuprolide Therapy for Prostate Cancer An Association with Scintigraphic “Flare” on Bone ScanClinical Nuclear Medicine, 1990
- Prevention of the Transient Adverse Effects of a Gonadotropin-Releasing Hormone Analogue (Buserelin) in Metastatic Prostatic Carcinoma by Administration of an Antiandrogen (Nilutamide)New England Journal of Medicine, 1989
- Phase III studies to compare goserelin (zoladex) with orchiectomy and with diethylstilbestrol in treatment of prostatic carcinomaUrology, 1989
- Importance of early tumour exacerbation in patients treated with long acting analogues of gonadotrophin releasing hormone for advanced prostatic cancer.BMJ, 1985
- DISEASE FLARE INDUCED BY D-Trp6-LHRH ANALOGUE IN PATIENTS WITH METASTATIC PROSTATIC CANCERThe Lancet, 1984
- Tamoxifen flare in advanced breast cancerJAMA, 1978